FORMELA JEAN FRANCOIS sold $4K of KRRO (indirect holdings)
FORMELA JEAN FRANCOIS sold 300 indirectly-held shares of Korro Bio, Inc. (KRRO) at $13.96 across 2 trades on 2026-08-26 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The director's sale is modest and pre‑arranged, so it likely has minimal impact on KRRO's share price.
Market read
Routine insider transaction with negligible trading relevance.
What to watch
Potential upcoming dilution or secondary offerings could make any insider sell more meaningful.
Background
SEC Form 4 filing discloses insider transactions; investors monitor these for signals.
Ticker impact
Director sold 300 shares for $4,188 via a 10b5-1 plan on 2026-08-26
No significant price impact expected.
The transaction size is small relative to float and was pre‑arranged, so market participants typically view it as routine.
Market effects
No sector‑wide implications; the sale is company‑specific.
No regional impact; the filing is a routine US disclosure.
Not relevant to global markets.
Counterpoint
Even small insider sales can signal concerns, but the 10b5‑1 plan suggests no new information.
Key entities
- DirectorFORMELA JEAN FRANCOIS
Insider who sold shares.
- CompanyKorro Bio, Inc.
Biotech firm listed under ticker KRRO.